Korro Bio, Inc. Common Stock (KRRO) is a publicly traded Healthcare sector company. As of November 11, 2026, KRRO trades at $15.84 with a market cap of $220.30M and a P/E ratio of -0.97. KRRO moved +5.41% today. Year to date, KRRO is +96.71%; over the trailing twelve months it is -51.46%. Its 52-week range spans $5.20 to $55.89. Analyst consensus is strong buy with an average price target of $19.83. Rallies surfaces KRRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for KRRO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $15.84 |
| Market Cap | $220.30M |
| P/E Ratio | -0.97 |
| EPS | $-10.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.89 |
| 52-Week Low | $5.20 |
| Volume | 174.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.38M |
| Net Income | $-106.64M |
| Gross Margin | 0.00% |
6 analysts cover KRRO: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.83.